GPCR logo

Structure Therapeutics (GPCR)

Profile

Full Name

Structure Therapeutics Inc.

Ticker Symbol

GPCR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 3, 2023

Indexes

Not included

Website

http://structuretx.com

Employees

163

Key Details

Price

$15.53(+9.72%)

Market cap

$890.25M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.34(+3.70% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$15.53
GPCR price is $15.53

30-Day Relative Volume

1.49
GPCR 30-day relative volume is 1.49

Price Performance

Price Today change

+9.72%
GPCR price is up +9.72% today

Price YTD change

-42.75%
GPCR price is down -42.75% since January 1st

Price 1-year change

-62.57%
GPCR price is down -62.57% year-on-year

Price 3-year change

-
GPCR price 3-year change is unknown

Price Range

Price All-time high

$75.02
GPCR price is currently -79.30% below its historical high of $75.02

Price 3-year low

$13.73
GPCR price is currently +13.07% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$890.25M
GPCR market capitalization is $890.25 million

Market cap 3-year change

-
GPCR market capitalization 3-year change is unknown

Market cap All-time high

$3.43B
GPCR market capitalization is currently -74.06% below its historical high of $3.43 billion

Market cap sector rank

75.68%
GPCR market capitalization is higher than 75.68% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+23%
GPCR shares outstanding is up +23% year-on-year

Shares Outstanding 3-Year Change

-
GPCR shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.07
GPCR beta is 1.07

200-day SMA

$32.77
GPCR price is currently -52.62% below its 200-day simple moving average

50-day SMA

$22.54
GPCR price is currently -31.13% below its 50-day simple moving average

RSI

26.92
GPCR 14-day relative strength index is 26.92

Volume

1.49
GPCR 30-day relative volume is 1.49

ATR

$1.52
GPCR average true range is $1.52

10-day Historical Volatility

87.03%
GPCR 10-day historical volatility is 87.03%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
GPCR annual revenue value is unknown

Revenue Analysts estimate

$45.45M
GPCR annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
GPCR annual revenue 1-year change is unknown

Revenue Sector rank

-
GPCR annual revenue is unknown

EPS

EPS

-$2.34
GPCR annual earnings per share is -$2.34

EPS Analysts estimate

-$0.68
GPCR annual earnings per share is currently +243.11% higher than the consensus analysts' forecast

EPS 1-year change

+3.7%
GPCR annual earnings per share is up +3.7% year-on-year

EPS Sector rank

35.29%
GPCR annual earnings per share is higher than 35.29% of companies in Healthcare sector

Profit

Gross profit

-
GPCR annual gross profit value is unknown

Gross margin

-
GPCR annual gross profit margin value is unknown

Operating profit

-$158.23M
GPCR annual operating income is -$158.23 million

Operating margin

-
GPCR annual operating profit margin value is unknown

Net income

-$122.53M
GPCR annual net profit is -$122.53 million

Net margin

-
GPCR annual net profit margin value is unknown

Expenses

Total expenses

$158.23M
GPCR annual total expenses is $158.23 million

Operating expenses

$158.23M
GPCR annual total operating expenses is $158.23 million

Cost of goods sold

-
GPCR annual cost of goods sold value is unknown

Selling, general & administrative expenses

$49.41M
GPCR annual SGA is $49.41 million

Depreciation and amortization

$992.00K
GPCR annual depreciation & amortization is $992.00 thousand

Interest expense

-
GPCR annual interest expense value is unknown

Income tax

$310.00K
GPCR annual income tax is $310.00 thousand

EBIT & EBITDA

EBIT

-$158.23M
GPCR annual earnings before interest & taxes is -$158.23 million

EBITDA

-$157.24M
GPCR annual EBITDA is -$157.24 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$903.33M
GPCR annual total assets is $903.33 million

Non current assets

$12.12M
GPCR annual long term assets is $12.12 million

Current assets

$891.21M
GPCR annual total current assets is $891.21 million

Cash and cash equivalents

$169.51M
GPCR annual cash & cash equivalents is $169.51 million

Accounts receivable

-
GPCR annual accounts receivable value is unknown

Inventory

-
GPCR annual inventory value is unknown

Liabilities

Total liabilities

$38.49M
GPCR annual total liabilities is $38.49 million

Long term liabilities

$2.47M
GPCR annual total long term liabilities is $2.47 million

Current liabilities

$36.02M
GPCR annual total current liabilities is $36.02 million

Accounts payable

$8.02M
GPCR annual accounts payable is $8.02 million

Debt

Total debt

$3.86M
GPCR annual total debt is $3.86 million

Total debt 1-year change

-29.18%
GPCR annual total debt is down -29.18% year-on-year

Long term debt

$2.16M
GPCR annual long term debt is $2.16 million

Short term debt

$1.70M
GPCR annual short term debt is $1.70 million

Equity & Capital

Shareholders equity

$864.84M
GPCR annual stockholders equity is $864.84 million

Book value

$864.84M
GPCR annual book value is $864.84 million

Retained earnings

-$329.10M
GPCR annual retained earnings is -$329.10 million

Working capital

$855.19M
GPCR annual working capital is $855.19 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$116.64M
GPCR annual cash flow from operations is -$116.64 million

Cash from operations 1-year change

-46.73%
GPCR annual cash flow from operations is down -46.73% year-on-year

Cash from investing

-$358.91M
GPCR annual cash flow from investing activities is -$358.91 million

Cash from investing 1-year change

-33.75%
GPCR annual cash flow from investing activities is down -33.75% year-on-year

Cash from financing

$515.26M
GPCR annual cash flow from financing activities is $515.26 million

Cash from financing 1-year change

+14.11%
GPCR annual cash flow from financing activities is up +14.11% year-on-year

CAPEX

CAPEX

-
GPCR annual capital expenditures value is unknown

CAPEX 1-year change

-
GPCR annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$117.93M
GPCR annual free cash flow is -$117.93 million

Free cash flow 1-year change

-44.42%
GPCR annual free cash flow is down -44.42% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
GPCR annual gross profit margin value is unknown

Operating margin

-
GPCR annual operating profit margin value is unknown

Net margin

-
GPCR annual net profit margin value is unknown

ROA & ROE

ROA

-13.56%
GPCR annual return on assets is -13.56%

ROE

-14.17%
GPCR annual return on equity is -14.17%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
GPCR price to earnings ratio value is unknown

PE ratio Sector rank

-
GPCR price to earnings ratio is unknown

PB Ratio

PB ratio

1.03
GPCR price to book ratio is 1.03

PB ratio Sector rank

45.39%
GPCR price to book ratio is higher than 45.39% of companies in Healthcare sector

PS Ratio

PS ratio

-
GPCR price to sales ratio value is unknown

PS ratio Sector rank

-
GPCR price to sales ratio is unknown

Enterprise value

Enterprise value

$724.60M
GPCR enterprise value is $724.60 million

Enterprise value Sector rank

73.29%
GPCR enterprise value is higher than 73.29% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-4.61
GPCR EV/EBITDA is -4.61

EV/EBITDA Sector rank

18.84%
GPCR EV/EBITDA is higher than 18.84% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

24.74
GPCR annual current ratio is 24.74

Quick ratio

-
GPCR annual quick ratio value is unknown

Leverage

Debt to equity

0.00
GPCR annual debt to equity ratio is 0.00

Interest coverage ratio

-
GPCR annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
GPCR piotroski f-score value is unknown

Altman Z-Score

-
GPCR altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Feb 28, 25 William Blair
Outperform
Feb 28, 25 Citizens Capital Markets
Market Outperform
Jan 8, 25 Stifel
Buy
Dec 20, 24 HC Wainwright & Co.
Buy
Dec 19, 24 HC Wainwright & Co.
Buy
Dec 18, 24 JMP Securities
Market Outperform
Dec 4, 24 HC Wainwright & Co.
Buy
Sep 23, 24 Morgan Stanley
Overweight
Sep 23, 24 Cantor Fitzgerald
Overweight
Sep 16, 24 Cantor Fitzgerald
Overweight

Institutional Ownership

Similar stocks

GERN logo
Geron (GERN)
COLL logo
Collegium Pharmaceutical (COLL)
CMRX logo
Chimerix (CMRX)
HROW logo
Harrow Health (HROW)
ESTA logo
Establishment Labs Holdings (ESTA)
PNTG logo
Pennant (PNTG)
ELVN logo
Enliven Therapeutics (ELVN)
DYN logo
Dyne Therapeutics (DYN)
WVE logo
Wave Life Sciences (WVE)
  • What is the ticker symbol for Structure Therapeutics?
  • Does Structure Therapeutics pay dividends?
  • What sector is Structure Therapeutics in?
  • What industry is Structure Therapeutics in?
  • What country is Structure Therapeutics based in?
  • When did Structure Therapeutics go public?
  • Is Structure Therapeutics in the S&P 500?
  • Is Structure Therapeutics in the NASDAQ 100?
  • Is Structure Therapeutics in the Dow Jones?
  • When was Structure Therapeutics's last earnings report?
  • When does Structure Therapeutics report earnings?
  • Should I buy Structure Therapeutics stock now?

What is the ticker symbol for Structure Therapeutics?

The ticker symbol for Structure Therapeutics is NASDAQ:GPCR

Does Structure Therapeutics pay dividends?

No, Structure Therapeutics does not pay dividends

What sector is Structure Therapeutics in?

Structure Therapeutics is in the Healthcare sector

What industry is Structure Therapeutics in?

Structure Therapeutics is in the Biotechnology industry

What country is Structure Therapeutics based in?

Structure Therapeutics is headquartered in United States

When did Structure Therapeutics go public?

Structure Therapeutics's initial public offering (IPO) was on February 3, 2023

Is Structure Therapeutics in the S&P 500?

No, Structure Therapeutics is not included in the S&P 500 index

Is Structure Therapeutics in the NASDAQ 100?

No, Structure Therapeutics is not included in the NASDAQ 100 index

Is Structure Therapeutics in the Dow Jones?

No, Structure Therapeutics is not included in the Dow Jones index

When was Structure Therapeutics's last earnings report?

Structure Therapeutics's most recent earnings report was on Feb 27, 2025

When does Structure Therapeutics report earnings?

The next expected earnings date for Structure Therapeutics is May 9, 2025

Should I buy Structure Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page